At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FENC Fennec Pharmaceuticals Inc.
Market Closed 05-17 16:00:00 EDT
7.04
-0.08
-1.12%
盘后7.04
+0.000.00%
17:52 EDT
High7.09
Low6.70
Vol306.74K
Open7.03
D1 Closing7.12
Amplitude5.48%
Mkt Cap192.35M
Tradable Cap109.15M
Total Shares27.32M
T/O2.11M
T/O Rate1.98%
Tradable Shares15.50M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.